Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on brain & cognitive health. Browse all Brain & Cognitive Health education
Anxiety is one of the most common mental-health experiences, and researchers increasingly ask why some people are more prone to it than others. One gene draws sustained attention: RGS2, short for regulator of G protein signaling 2. RGS2 acts as a molecular brake on signaling inside brain cells, and variation in the gene has been linked in multiple studies to differences in anxiety susceptibility, stress reactivity, and emotional resilience.
What the RGS2 gene does
RGS2 produces a protein that dials down signaling from G protein-coupled receptors — a large family of receptors the brain uses to respond to neurotransmitters like serotonin, norepinephrine, and glutamate. By accelerating the "off" switch on these receptors, RGS2 helps determine how strongly and how long a cell responds to a chemical message. In circuits that govern fear and stress, the tuning of that brake matters for how the brain handles threat.
RGS2 and G protein signaling in the brain
G protein-coupled receptors sit at the front line of neurotransmission. When RGS2 activity is lower, receptor signaling stays switched on longer, which can amplify the response of fear and stress circuits in regions like the amygdala. When RGS2 activity is adequate, signaling resolves more quickly. This is why a regulator most people have never heard of can influence something as personal as how easily worry takes hold and how long it lingers.
The rs4606 variant and anxiety research
The most studied RGS2 variant is rs4606, located in a region that affects how much RGS2 protein is made. Human studies have associated certain rs4606 genotypes with reduced RGS2 expression and higher measures of anxiety, introverted temperament, and stress sensitivity, and animal models in which RGS2 is removed show heightened anxiety-like behavior. The effect is modest and probabilistic — one contributing factor among many, not a switch that determines outcome.
RGS2 beyond anxiety: stress and resilience
Research on RGS2 extends into how people recover from acute stress and adversity. Some studies have examined its role in stress-related responses following traumatic events, framing RGS2 as part of the broader resilience machinery rather than a simple "anxiety gene." The picture that emerges is of a regulator that shapes the intensity and duration of stress responses, interacting with life experience to influence emotional balance over time.
Genetics as one input among many
A variant like rs4606 does not decide whether you will feel anxious. Sleep, stress load, coping skills, social support, and other genes all shape the outcome. Genetics is a guide, not a guarantee. Understanding your predispositions is valuable because it points toward the modifiable levers worth discussing with a provider. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights across stress-response and neurotransmitter pathways, offering pathway-level context — PlexusDx tells you about your biology; it does not tell you what to put in your body.
Interested in how your stress-response pathway variants read? Take the Precision Peptide Genetic Test to learn how your genes shape these pathways — the "test before you invest" approach that turns guesswork into an informed conversation with your provider.
The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways. It does not recommend, prescribe, or determine which peptides you should use, and it does not diagnose, treat, or prevent any medical condition. Consult a qualified healthcare provider before beginning any peptide protocol.
Frequently Asked Questions About RGS2 and Anxiety
What is the RGS2 gene?
RGS2 codes for regulator of G protein signaling 2, a protein that acts as a brake on receptor signaling inside brain cells. By speeding up the shutoff of G protein-coupled receptors, it helps control how strongly neurons respond in fear and stress circuits, influencing anxiety-related traits.
Does the RGS2 rs4606 variant cause anxiety?
No single variant causes anxiety. Research links certain rs4606 genotypes to lower RGS2 expression and modestly higher anxiety and stress sensitivity, and animal studies support a role. But the effect is small and probabilistic — one contributing factor interacting with environment, not a deterministic cause.
Can a genetic test diagnose an anxiety disorder?
No. Genetic testing does not diagnose anxiety disorders, and PlexusDx does not. Diagnosis is a clinical process performed by a qualified provider. Genetic insight describes pathway-level predispositions in stress-response and neurotransmitter systems, offering educational context that supports, but never replaces, professional evaluation and care.
If I carry the variant, will I always be anxious?
No. Genetic variants shift probabilities, not destinies. RGS2 interacts with sleep, stress, coping skills, support systems, and other genes. Many carriers experience little anxiety. Lifestyle strategies and, when appropriate, professional support discussed with your provider address the large modifiable side of the equation.
This article is part of the PlexusDx Education Hub. Browse all Brain & Cognitive Health education
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Why Do Some People Get Bronchitis More Often Than Others?
Genetic Factors in Dry Eye: Tear Film, Inflammation, and DNA